Dollars for Docs

How Industry Dollars Reach Your Doctors

REVLIMID
drug

REVLIMID

Treats myelodysplastic syndrome (MDS). Also treats cancer, including multiple myeloma (plasma cell cancer) and mantle cell lymphoma (MCL).
Cash
$12.3M

payments related to this drug

Doctor
7,382

doctors receiving payments

Company
1

company making payments related to this drug

Drug
49%

of payments for this drug were also associated with another product

Companies Making Payments Related to this Drug

Aggregate totals are shown, including payments to doctors and teaching hospitals. To purchase bulk data, please visit the ProPublica Data Store.

Company Payment
CELGENE CORPORATION $12.3M

Top Doctors Receiving Payments Related to this Drug

Totals listed account for all payments from August 2013 to December 2016.

Doctor Location Money Paid
VESCIO
ROBERT VESCIO

WEST HOLLYWOOD, CA

$245K
BOCCIA
RALPH BOCCIA

BETHESDA, MD

$200K
TABBARA
IMADEDDINE TABBARA

WASHINGTON, DC

$193K
MARK
TOMER MARK

AURORA, CO

$167K
Mazumder
Amitabha Mazumder

NEW YORK, NY

$134K
NIESVIZKY
RUBEN NIESVIZKY

NEW YORK, NY

$131K
WHITE
WILLIAM WHITE

FARMINGTON, CT

$128K
SCHRIBER
JEFFREY SCHRIBER

SCOTTSDALE, AZ

$120K
Solh
Melhem Solh

ATLANTA, GA

$118K
Berenson
James Berenson

WEST HOLLYWOOD, CA

$110K

Top Teaching Hospitals Receiving Payments Related to this Drug

Note: We have made some effort to normalize the data and eliminate duplicates, but data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].